Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.52 |
| ▸ | CES1 | P23141 | 3/20 | 0.52 |
| ▸ | PPARG | P37231 | 8/20 | 0.52 |
| ▸ | PPARA | Q07869 | 8/20 | 0.52 |
| ▸ | PPARD | Q03181 | 6/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.50 |
| ▸ | FABP4 | P15090 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TLR2 | O60603 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.50 |
| ▸ | TERT | O14746 | 2/20 | 0.50 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3212902 | 1.00 | CES2 (0.52) | CES2CES1PPARGPPARAPPARD | |
| SCHEMBL30675 | 1.00 | CES2 (0.52) | CES2CES1PPARGPPARAPPARD | |
| SCHEMBL572485 | 1.00 | CES2 (0.52) | CES2CES1PPARGPPARAPPARD | |
| SCHEMBL3512333 | 1.00 | CES2 (0.52) | CES2CES1PPARGPPARAPPARD | |
| SCHEMBL7180871 | 1.00 | CES2 (0.52) | CES2CES1PPARGPPARAPPARD | |
| SCHEMBL3330873 | 0.98 | TRPA1 (0.52) | CES2CES1PPARGPPARAPPARD | |
| SCHEMBL3397001 | 0.95 | PPARG (0.56) | CES2CES1PPARGPPARAPPARD | |
| SCHEMBL624501 | 0.95 | PPARG (0.56) | CES2CES1PPARGPPARAPPARD | |
| SCHEMBL1173224 | 0.95 | PPARG (0.56) | CES2CES1PPARGPPARAPPARD | |
| SCHEMBL9868698 | 0.95 | PPARG (0.56) | CES2CES1PPARGPPARAPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4103710-A1 | VIABLE BACTERIAL HOST CELL | Inbiose N.V. (BE) | 2022-12-21 | — | — | EP | claimed |
| US-20220396761-A1 | VIABLE BACTERIAL HOST CELL | INBIOSE N.V. (BE) | 2022-12-15 | — | — | US | claimed |
| WO-2021160829-A1 | VIABLE BACTERIAL HOST CELL | INBIOSE N.V. (BE) | 2021-08-19 | — | — | WO | claimed |
| CN-102294015-A | Medicinal composition for targeted therapy of tumors and preparation method of medicinal composition | — | 2011-12-28 | — | — | CN | claimed |
| WO-2010019813-A2 | PRODUCTION OF FATTY ACTDS BY GENETICALLY MODIFIED PHOTOSYNTHETIC ORGANISMS | SAPPHIRE ENERGY, INC. (US) | 2010-02-18 | — | — | WO | claimed |
| WO-2024096120-A1 | MICROORGANISM HAVING IMPROVED COLONIZATION PROPERTIES IN HOST AND METHOD FOR PRODUCING SAME | 株式会社バイオパレット | 2024-05-10 | — | — | WO | disclosed |
| WO-2024096123-A1 | GENETICALLY MODIFIED MICROORGANISM AND METHOD FOR PRODUCING SAME | 株式会社バイオパレット | 2024-05-10 | — | — | WO | disclosed |
| US-20240076704-A1 | PRODUCTION OF BIOPRODUCT IN A HOST CELL | INBIOSE N.V. (BE) | 2024-03-07 | — | — | US | disclosed |
| CN-111492058-B | Bacteria that constitutively produce monophosphoryl lipid a and method for producing monophosphoryl lipid a using the same | 韩国科学技术研究院 | 2024-03-05 | — | — | CN | disclosed |
| CN-116916944-A | Vaccine, therapeutic agent and RNA delivery platform based on immunostimulatory bacteria | 阿克蒂姆治疗有限公司 | 2023-10-20 | — | — | CN | disclosed |
| US-11781160-B2 | Methods for the production of methacrylates | Mitsubishi Chemical UK Limited (GB) | 2023-10-10 | — | — | US | disclosed |
| EP-4196139-A2 | IMMUNOSTIMULATORY BACTERIA-BASED VACCINES, THERAPEUTICS, AND RNA DELIVERY PLATFORMS | Actym Therapeutics, Inc. (US) | 2023-06-21 | — | — | EP | disclosed |
| US-20130089899-A1 | INDUSTRIAL FATTY ACID ENGINEERING GENERAL SYSTEM FOR MODIFYING FATTY ACIDS | KIVERDI, INC. (US) | 2013-04-11 | — | — | US | disclosed |
| EP-2575486-A1 | FOOD COMPOSITIONS COMPRISING TAILORED OILS | Solazyme, Inc. (US) | 2013-04-10 | — | — | EP | disclosed |
| US-20120070490-A1 | ANTI-TRYPANOSOMAL PEPTIDES AND USES THEREOF | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2012-03-22 | — | — | US | disclosed |
| CN-102294015-A | Medicinal composition for targeted therapy of tumors and preparation method of medicinal composition | — | 2011-12-28 | — | — | CN | disclosed |
| WO-2011150411-A1 | FOOD COMPOSITIONS COMPRISING TAILORED OILS | SOLAZYME, INC. (US) | 2011-12-01 | — | — | WO | disclosed |
| US-20100322903-A1 | ENGINEERED BACTERIOPHAGES AS ADJUVANTS FOR ANTIMICROBIAL AGENTS AND COMPOSITIONS AND METHODS OF USE THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2010-12-23 | — | — | US | disclosed |
| WO-2010129267-A2 | ANTI-TRYPANOSOMAL PEPTIDES AND USES THEREOF | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2010-11-11 | — | — | WO | disclosed |
| US-5211721-A | Octane requirement increases with polyether compounds | TEXACO INC. (US) | 1993-05-18 | — | — | US | disclosed |